Clinical trial
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
NCT00006401 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00006401 |
|---|---|
| Title | Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants |
| Official title | Inhaled NO for the Prevention of Chronic Lung Disease |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Diseases, Bronchopulmonary Dysplasia |
| Intervention type | Drug, Other |
| Interventions | iNO, Placebo |
| Enrollment | 793 |
| Start date | Sep 1, 2000 |
| Primary completion | Sep 1, 2005 |
| Completion | Oct 1, 2007 |
| First posted | Oct 13, 2000 |
| Last update posted | Oct 6, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: